Società Acura Pharmaceuticals, Inc. Other OTC
Azioni
ACUR
US00509L8028
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Vendite per regione
USD in Milioni | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/03/98 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 01/02/09 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/03/98 |
William Skelly
BRD | Director/Board Member | 73 | 01/05/96 |
Director/Board Member | 53 | 01/12/02 | |
George Ross
BRD | Director/Board Member | 82 | 01/01/08 |
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 66 001 783 | 10 081 080 ( 15,27 %) | 0 | 15,27 % |
Coordinate società
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |